Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms

被引:188
作者
Li, Y [1 ]
Zimmermann, B [1 ]
Rusterholz, C [1 ]
Kang, AJ [1 ]
Holzgreve, W [1 ]
Hahn, S [1 ]
机构
[1] Univ Basel, Womens Hosp, Dept Res, Lab Prenatal Med, CH-4031 Basel, Switzerland
关键词
D O I
10.1373/clinchem.2003.029835
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Analysis of fetal DNA in maternal plasma has recently been introduced as a new method for noninvasive prenatal diagnosis, particularly for the analysis of fetal genetic traits, which are absent from the maternal genome, e.g., RHD or Y-chromosome-specific sequences. To date, the analysis of other fetal genetic traits has been more problematic because of the overwhelming presence of maternal DNA sequences in the circulation. We examined whether different biochemical properties can be discerned between fetal and maternal circulatory DNA. Methods: Plasma DNA was examined by agarose gel electrophoresis. The fractions of fetal and maternal DNA in size-fractionated fragments were assayed by real-time PCR. The determination of paternally and maternally inherited fetal genetic traits was examined by use of highly polymorphic chromosome-21-specific microsatellite markers. Results: Size fractionation of circulatory DNA indicated that the major portion of cell-free fetal DNA had an approximate molecular size of <0.3 kb, whereas maternally derived sequences were, on average, considerably larger than 1 kb. Analysis of size-fractionated DNA (less than or equal to0.3 kb) from maternal plasma samples facilitated the ready detection of paternally and maternally inherited microsatellite markers. Conclusions: Circulatory fetal DNA can be enriched by size selection of fragment sizes less than similar to0.3kb. Such selection permits easier analysis of both paternally and maternally inherited DNA polymorphisms. (C) 2004 American Association for Clinical Chemistry.
引用
收藏
页码:1002 / 1011
页数:10
相关论文
共 29 条
  • [1] Size distributions of maternal and fetal DNA in maternal plasma
    Chan, KCA
    Zhang, J
    Hui, ABY
    Wong, N
    Lau, TK
    Leung, TN
    Lo, KW
    Huang, DWS
    Lo, YMD
    [J]. CLINICAL CHEMISTRY, 2004, 50 (01) : 88 - 92
  • [2] Chen CP, 2000, PRENATAL DIAG, V20, P355, DOI 10.1002/(SICI)1097-0223(200004)20:4<355::AID-PD800>3.0.CO
  • [3] 2-#
  • [4] Chiu Rossa W K, 2002, Expert Rev Mol Diagn, V2, P32, DOI 10.1586/14737159.2.1.32
  • [5] Prenatal exclusion of β thalassaemia major by examination of maternal plasma
    Chiu, RWK
    Lau, TK
    Leung, TN
    Chow, KCK
    Chui, DHK
    Lo, YMD
    [J]. LANCET, 2002, 360 (9338) : 998 - 1000
  • [6] Chiu RWK, 2002, CLIN CHEM, V48, P778
  • [7] Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy
    Farina, A
    LeShane, ES
    Lambert-Messerlian, GM
    Canick, JA
    Lee, T
    Neveux, LM
    Palomaki, GE
    Bianchi, DW
    [J]. CLINICAL CHEMISTRY, 2003, 49 (02) : 239 - 242
  • [8] Cell-free DNA in human blood plasma: Length measurements in patients with pancreatic cancer and healthy controls
    Giacona, MB
    Ruben, GC
    Iczkowski, KA
    Roos, TB
    Porter, DM
    Sorenson, GD
    [J]. PANCREAS, 1998, 17 (01) : 89 - 97
  • [9] Kinetics of SRY gene appearance in maternal serum:: detection by real time PCR in early pregnancy after assisted reproductive technique
    Guibert, J
    Benachi, A
    Grebille, AG
    Ernault, P
    Zorn, JR
    Costa, JM
    [J]. HUMAN REPRODUCTION, 2003, 18 (08) : 1733 - 1736
  • [10] Prenatal diagnosis using fetal cells and cell-free fetal DNA in maternal blood: What is currently feasible?
    Hahn, S
    Holzgreve, W
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2002, 45 (03) : 649 - 656